Cowealth Medical Holding Co., Ltd. (TPEX:4745)
Taiwan · Delayed Price · Currency is TWD 21.45
-0.25 (-1.15%)
Feb 11, 2026, 1:30 PM CST
Cowealth Medical Holding Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 3,409 | 4,193 | 4,813 | 5,626 | 5,140 | 4,722 | |
Revenue Growth (YoY) | -20.86% | -12.88% | -14.46% | 9.47% | 8.85% | 1.22% |
Cost of Revenue | 2,874 | 3,401 | 3,828 | 4,522 | 4,082 | 3,698 |
Gross Profit | 534.54 | 791.52 | 984.45 | 1,104 | 1,058 | 1,024 |
Selling, General & Admin | 576.32 | 683.78 | 726.97 | 701.99 | 687.62 | 617.93 |
Research & Development | 15.74 | 16.7 | 13.96 | 12.36 | - | - |
Operating Expenses | 614.09 | 694.39 | 720.28 | 734.62 | 718.09 | 685.82 |
Operating Income | -79.56 | 97.13 | 264.17 | 369.83 | 339.84 | 338.02 |
Interest Expense | -27.88 | -28.92 | -34.74 | -24.97 | -24.39 | -36.17 |
Interest & Investment Income | 19.52 | 11.28 | 20.41 | 37.25 | 10.58 | 12.87 |
Earnings From Equity Investments | -0.07 | 0.64 | 0.5 | 0.11 | -0.07 | -0.08 |
Currency Exchange Gain (Loss) | -7.05 | 0.74 | -1.49 | -1.37 | -1.59 | 1.46 |
Other Non Operating Income (Expenses) | 1.28 | 4.36 | -6.05 | 5.92 | 10.38 | 7.95 |
EBT Excluding Unusual Items | -93.77 | 85.22 | 242.79 | 386.76 | 334.75 | 324.04 |
Gain (Loss) on Sale of Investments | 1.6 | 1.82 | 14.87 | -0.14 | - | 4.31 |
Gain (Loss) on Sale of Assets | 1.61 | 1.74 | 0.63 | -0.79 | -0.02 | -13.47 |
Other Unusual Items | 0.21 | 0.14 | 0.01 | 2.52 | - | 0.05 |
Pretax Income | -90.34 | 88.92 | 258.31 | 388.34 | 334.74 | 314.94 |
Income Tax Expense | 6.91 | 40.93 | 119.95 | 153.14 | 118.82 | 106.02 |
Earnings From Continuing Operations | -97.25 | 48 | 138.36 | 235.2 | 215.91 | 208.92 |
Minority Interest in Earnings | 17.57 | -47.37 | -89.25 | -141.08 | -76.45 | -84.52 |
Net Income | -79.68 | 0.63 | 49.11 | 94.12 | 139.46 | 124.39 |
Net Income to Common | -79.68 | 0.63 | 49.11 | 94.12 | 139.46 | 124.39 |
Net Income Growth | - | -98.72% | -47.82% | -32.52% | 12.12% | -55.53% |
Shares Outstanding (Basic) | 77 | 77 | 77 | 77 | 77 | 77 |
Shares Outstanding (Diluted) | 77 | 77 | 77 | 77 | 78 | 77 |
Shares Change (YoY) | - | -0.03% | -0.02% | -0.02% | 0.02% | 0.05% |
EPS (Basic) | -1.03 | 0.01 | 0.63 | 1.22 | 1.80 | 1.61 |
EPS (Diluted) | -1.03 | 0.01 | 0.63 | 1.21 | 1.80 | 1.61 |
EPS Growth | - | -98.71% | -47.93% | -32.78% | 12.07% | -55.51% |
Free Cash Flow | 1,120 | 316.52 | -161.34 | -286.27 | -152.91 | 777.31 |
Free Cash Flow Per Share | 14.46 | 4.09 | -2.08 | -3.69 | -1.97 | 10.03 |
Dividend Per Share | - | - | 0.400 | 1.600 | 1.500 | 1.200 |
Dividend Growth | - | - | -75.00% | 6.67% | 25.00% | 5.00% |
Gross Margin | 15.68% | 18.88% | 20.46% | 19.63% | 20.58% | 21.68% |
Operating Margin | -2.33% | 2.32% | 5.49% | 6.57% | 6.61% | 7.16% |
Profit Margin | -2.34% | 0.01% | 1.02% | 1.67% | 2.71% | 2.63% |
Free Cash Flow Margin | 32.85% | 7.55% | -3.35% | -5.09% | -2.97% | 16.46% |
EBITDA | -35.51 | 141.47 | 315.66 | 405.52 | 388.75 | 429.22 |
EBITDA Margin | -1.04% | 3.37% | 6.56% | 7.21% | 7.56% | 9.09% |
D&A For EBITDA | 44.05 | 44.34 | 51.48 | 35.7 | 48.91 | 91.2 |
EBIT | -79.56 | 97.13 | 264.17 | 369.83 | 339.84 | 338.02 |
EBIT Margin | -2.33% | 2.32% | 5.49% | 6.57% | 6.61% | 7.16% |
Effective Tax Rate | - | 46.02% | 46.44% | 39.43% | 35.50% | 33.66% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.